Delivery Order SPE2DB20D3103-SPE2DB25FQ4P3
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMURAN 50 MG TABLET 100S. The contract has a ceiling value of $1,203.46 and an ultimate completion date of March 30, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 23, 2025, for 100 tablets of Azathioprine 50 mg. This is a firm fixed-price, non-set-aside contract valued at $1,335.54, with an ultimate completion date of July 24, 2025. The place of performance is located in Conshohocken, Pennsylvania. This delivery order represents a single transaction within...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for azathioprine 100 mg tablets (100 count) on September 24, 2025, with a ceiling value of $2,122.54 and ultimate completion date of September 25, 2025. This competitively awarded, firm fixed price delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract carries no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.63 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) on August 13, 2025, with completion expected by August 14, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract mechanism and represents a routine pharmaceutical procurement for federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,440.70 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The place of performance is listed in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $4,981.52 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with completion targeted for September 2, 2025. This non-competitive, non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,974.65 by the Defense Logistics Agency's Medical Supply Chain on July 4, 2025, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive federal pharmaceutical supply portfolio. The delivery order is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) with a ceiling value of $27,217.17. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,355.40 by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4P3Delivery Order
The Defense Logistics Agency awarded a $4,425.45 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Imuran 50 mg, with a completion date of September 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving the federal medical supply chain and fulfills critical pharmaceutical needs for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to deliver a broad range of medications and medical supplies, including specialty pharmaceuticals, brand-name and generic drugs, and medical devices across multiple therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/24/25 |